Taken together, these findings underscore the critical role of CDK4/6 in regulating cancer cell metabolism, highlighting how their inhibition may unveil metabolic vulnerabilities that can be therapeutically exploited to overcome resistance and improve patient outcomes. The gene discussed is CDK4; the disease is cancer.